Shots: Generate Biomedicines and Zealand Pharma entered a strategic collaboration to develop multispecific protein therapeutics for obesity and other metabolic diseases using Generate’s generative AI platform and Zealand Pharma’s metabolic health expertise Under the agreement, Generate will receive $30M upfront, up to $35M in early preclinical milestones, and is eligible for nearly $1.2B including potential development,…